Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-28

Clinical Trial Update: Advanced Neuroimaging Evaluation of the Central Nervous System Biological Changes Associated With Efavirenz Therapy and Switch to an Elvitegravir-based Regimen [NA]

View source ↗

Summary

This completed clinical trial evaluated central nervous system changes associated with efavirenz treatment and after switching to an elvitegravir-based regimen.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sustiva (efavirenz)
  • Vitekta (elvitegravir)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: HIV Disease | NA | Status: COMPLETED | Results posted: 2017-07-28